Oncogenic roles of CEACAM6 in pancreatic ductal adenocarcinoma.

被引：0
|
作者：
Mahadevan, Daruka
Pandey, Ritu
Chen, Yuliang
Essif, Jacob
Al-Khinji, Aisha
机构：
[1] Univ Texas Hlth San Antonio, San Antonio, TX USA
[2] Arizona Canc Ctr, Tucson, AZ USA
[3] Univ Arizona, Ctr Canc, Tucson, AZ USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16744
引用
收藏
页数：1
相关论文
共 50 条
  • [21] Expression profiling of CEACAM6 associated with the tumorigenesis and progression in gastric adenocarcinoma
    Deng, X.
    Liu, P.
    Zhao, Y.
    Wang, Q.
    GENETICS AND MOLECULAR RESEARCH, 2014, 13 (03) : 7686 - 7697
  • [22] Clinical impact of sarcopenia on prognosis in pancreatic ductal adenocarcinoma.
    Ninomiya, Go
    Fujii, Tsutomu
    Yamada, Suguru
    Asano, Tomonari
    Takano, Nao
    Takami, Hideki
    Iwata, Naoki
    Kanda, Mitsuro
    Niwa, Yukiko
    Hayashi, Masamichi
    Kobayashi, Daisuke
    Tanaka, Chie
    Nakayama, Goro
    Sugimoto, Hiroyuki
    Fujiwara, Michitaka
    Koike, Masahiko
    Kodera, Yasuhiro
    JOURNAL OF CLINICAL ONCOLOGY, 2017, 35 (04)
  • [23] T-cell regulation in pancreatic ductal adenocarcinoma.
    Sivakumar, Shivan
    Abu-Shah, Enas
    Ahern, David
    Mangal, Nagina
    Reddy, Srikanth
    Rendek, Aniko
    Soonawalla, Zahir
    Silva, Michael
    Middleton, Mark
    Dustin, Michael L.
    CANCER IMMUNOLOGY RESEARCH, 2020, 8 (03) : 76 - 77
  • [24] The prognostic value of stroma desmoplasia in pancreatic ductal adenocarcinoma.
    Fokas, Emmanouil
    Silva, Michael A.
    D'Costa, Zenobia
    Bockelmann, Robin
    Soonawalla, Zahir
    Liu, Stanley K.
    O'Neill, Eric
    Mukherjee, Somnath
    McKenna, William Gillies
    Muschel, Ruth J.
    Wang, Lai Mun
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (04)
  • [25] Expression of CEACAM6 is a factor of independent prognostic significance in pancreatic cancer
    Matros, E
    Duxbury, MS
    Redston, M
    Ashley, SW
    Whang, EE
    GASTROENTEROLOGY, 2004, 126 (04) : A804 - A804
  • [26] Investigating the role of pancreatic intraepithelial neoplasia in development of pancreatic ductal adenocarcinoma.
    Kadiyala, Padma
    Carpenter, Eileen
    Elhossiny, Ahmed
    Zhang, Yaqing
    Nelson, Sarah
    Lima, Fatima
    Donahue, Katelyn
    Du, Wenting
    Mcgue, Jake
    Watkoske, Hannah
    Attebury, Holly
    Daley, Donnele
    Bednar, Filip
    Rao, Arvind
    Frankel, Timothy
    Di Magliano, Marina Pasca
    CANCER RESEARCH, 2022, 82 (22) : 153 - 154
  • [27] Intratumoral fibrin as a novel immunomodulatory factor in pancreatic ductal adenocarcinoma.
    Wahab, Riajul
    Karim, Mazharul
    Hassan, Md Mahedi
    Grippo, Paul
    Bisheshari, Faraz
    Al-Hilal, Taslim
    CANCER RESEARCH, 2022, 82 (22) : 116 - 117
  • [28] Evaluation of putative prognostic tissue biomarkers in pancreatic ductal adenocarcinoma.
    Winter, J. M.
    Tang, L. H.
    Klimstra, D. S.
    Brennan, M. F.
    O'Reilly, E. M.
    Jarnagin, W. R.
    Allen, P. J.
    JOURNAL OF CLINICAL ONCOLOGY, 2011, 29 (15)
  • [29] Retraction Note: CEACAM6 gene silencing impairs anoikis resistance and in vivo metastatic ability of pancreatic adenocarcinoma cells
    Mark S. Duxbury
    Hiromichi Ito
    Michael J. Zinner
    Stanley W. Ashley
    Edward E. Whang
    Oncogene, 2023, 42 : 939 - 939
  • [30] The tumor immune microenvironment is decisive in the survival of pancreatic ductal adenocarcinoma.
    Aziz, Hosein M.
    Saida, Lawlaw
    de Koning, Willem
    Stubbs, Andrew
    Li, Yunlei
    van Eijck, Casper H. J.
    Mustafa, Dana A. M.
    CANCER RESEARCH, 2021, 81 (22) : 80 - 81
12345